LITTLE GREEN PHARMA LIMITED (LGP)
Share Price Analysis and Chart

13/07/2026

1

Speculative Buy

$0.15

114.29%

Canaccord Genuity maintains a Speculative Buy rating for Little Green Pharma with its target price reduced to $0.15 following the release of its FY26 financial results and the completion of a transformative merger with Cannatrek.

Commentary concludes the transaction uniquely links the corporate asset infrastructure of the listed entity with Cannatrek's extensive domestic customer footprint and strong earnings baseline.

On a standalone basis, full-year group revenue increased 15% to $42.4m, driven by accelerating product volumes distributed across European export channels.

The analyst notes near-term financial projections carry some forecast variability given historical performance fluctuations and limited near-term visibility surrounding the newly consolidated structure.

Canaccord highlights cheap entry valuation multiples and long-term regulatory tailwinds as legislative adjustments expand patient recruitment caps across Germany and the UK.